Year archive

AstraZeneca PLC — 2025 filings

All 244 regulatory filings released by AstraZeneca PLC (AZN) in 2025, sourced directly from the official regulator.

244 Filings

2025 Period

2025 filings (244)

Filing	Released	Lang
Director/PDMR Shareholding Director's Dealing	2025-12-22	English
Enhertu granted BTD for post-neoadjuvant early BC Regulatory Filings	2025-12-22	English
Update on LATIFY Phase III trial of ceralasertib Regulatory Filings	2025-12-22	English
6-K Filing Foreign Filer Report	2025-12-22	English
6-K Filing Foreign Filer Report	2025-12-22	English
6-K Filing Foreign Filer Report	2025-12-22	English
Director/PDMR Shareholding Director's Dealing	2025-12-19	English
6-K Filing Foreign Filer Report	2025-12-19	English
Subcutaneous Saphnelo approved in EU Regulatory Filings	2025-12-16	English
Enhertu approved in US for 1L HER2+ metastatic BC Regulatory Filings	2025-12-16	English
6-K Filing Foreign Filer Report	2025-12-16	English
6-K Filing Foreign Filer Report	2025-12-16	English
HOLDING(S) IN COMPANY Foreign Filer Report	2025-12-04	English
Holding(s) in Company Major Shareholding Notification	2025-12-04	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-12-04	Swedish
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2025-12-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-12-01	English
Block listing Interim Review Share Issue/Capital Change	2025-12-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-12-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-12-01	English
IMFINZI APPROVED IN US FOR EARLY GASTRIC CANCER Foreign Filer Report	2025-11-26	English
Imfinzi approved in US for early gastric cancer Regulatory Filings	2025-11-26	English
ASTRAZENECA MANUFACTURING INVESTMENT IN MARYLAND Foreign Filer Report	2025-11-24	English
AstraZeneca manufacturing investment in Maryland Regulatory Filings	2025-11-24	English
KOSELUGO (SELUMETINIB) APPROVED IN THE US Foreign Filer Report	2025-11-20	English
Koselugo (selumetinib) approved in the US Regulatory Filings	2025-11-20	English
HOLDING(S) IN COMPANY Foreign Filer Report	2025-11-17	English
Holding(s) in Company Major Shareholding Notification	2025-11-17	English
Delisting Announcement 2025 Delisting Announcement	2025-11-14	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-11-14	English
Director/PDMR Shareholding Director's Dealing	2025-11-14	English
Regulatory Filings 2025 Regulatory Filings	2025-11-12	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-11-10	English
Director/PDMR Shareholding Director's Dealing	2025-11-10	English
9M AND Q3 2025 RESULTS Foreign Filer Report	2025-11-06	English
9M and Q3 2025 results Interim / Quarterly Report 9M 2025	2025-11-06	English
Interim / Quarterly Report 2025 Interim / Quarterly Report 9M 2025	2025-11-06	English
RESULT OF GENERAL MEETING Foreign Filer Report	2025-11-03	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-11-03	English
FORM 6-K Foreign Filer Report	2025-11-03	English
Result of General Meeting Declaration of Voting Results & Voting Rights Announcements	2025-11-03	English
Special Resolution Approved at General Meeting AGM Information	2025-11-03	English
Articles of Association approved at General Meeting Audit Report / Information FY 2025	2025-11-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-11-03	English
Result of General Meeting held on 3 November 2025 Declaration of Voting Results & Voting Rights Announcements	2025-11-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-11-03	English
DIRECTOR DECLARATION Foreign Filer Report	2025-10-28	English
KOSELUGO (SELUMETINIB) APPROVED IN THE EU Foreign Filer Report	2025-10-28	English
Director Declaration Board/Management Information	2025-10-28	English
Koselugo (selumetinib) approved in the EU Regulatory Filings	2025-10-28	English
TEZSPIRE APPROVED IN EU FOR CRSWNP Foreign Filer Report	2025-10-22	English
Tezspire Approved in EU for CRSwNP Regulatory Filings	2025-10-22	English
US FDA APPROVES TEZSPIRE IN CRSWNP Foreign Filer Report	2025-10-20	English
POSITIVE CHMP OPINION FOR SUBCUTANEOUS SAPHNELO Foreign Filer Report	2025-10-20	English
US FDA Approves Tezspire in CRSwNP Regulatory Filings	2025-10-20	English
Positive CHMP opinion for subcutaneous Saphnelo Regulatory Filings	2025-10-20	English
AGREEMENT WITH US GOVT TO LOWER MEDICINE PRICES Foreign Filer Report	2025-10-14	English
Agreement with US Govt to lower medicine prices Regulatory Filings	2025-10-13	English
BAXDROSTAT MET PRIMARY ENDPOINT IN BAX24 PH3 TRIAL Foreign Filer Report	2025-10-07	English
Baxdrostat met primary endpoint in Bax24 Ph3 trial Regulatory Filings	2025-10-07	English
DATROWAY IMPROVED OS AND PFS IN TROPION-BREAST02 Foreign Filer Report	2025-10-06	English
Datroway improved OS and PFS in TROPION-Breast02 Regulatory Filings	2025-10-06	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-10-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-10-01	English
Total voting rights Regulatory Filings	2025-10-01	English
ENHERTU IMPROVED IDFS IN EARLY BC IN DB-05 Foreign Filer Report	2025-09-29	English
AZN HARMONISES LISTING STRUCTURE Foreign Filer Report	2025-09-29	English
6-K Foreign Filer Report	2025-09-29	English
Enhertu improved IDFS in early BC in DB-05 Earnings Release Q3 2025	2025-09-29	English
Proposed new Articles of Association of AstraZeneca PLC Audit Report / Information	2025-09-29	English
Existing Articles of Association of AstraZeneca PLC marked up to show proposed changes Governance Information	2025-09-29	English
AZN harmonises listing structure Regulatory Filings	2025-09-29	English
Form of Proxy Proxy Solicitation & Information Statement	2025-09-29	English
Circular and Notice of General Meeting Proxy Solicitation & Information Statement	2025-09-29	English
AZN harmonises listing structure Share Issue/Capital Change	2025-09-29	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-09-25	English
Director/PDMR Shareholding Director's Dealing	2025-09-25	English
KOSELUGO RECOMMENDED FOR EU APPROVAL Foreign Filer Report	2025-09-22	English
TEZSPIRE RECOMMENDED FOR APPROVAL IN EU FOR CRSWNP Foreign Filer Report	2025-09-22	English
Koselugo recommended for EU approval Regulatory Filings	2025-09-22	English
Tezspire Recommended for Approval in EU for CRSwNP Regulatory Filings	2025-09-22	English
SAPHNELO MET PRIMARY ENDPOINT IN TULIP-SC Foreign Filer Report	2025-09-17	English
UPDATE ON RESOLUTE PHASE III TRIAL Foreign Filer Report	2025-09-17	English
Saphnelo met primary endpoint in TULIP-SC Regulatory Filings	2025-09-17	English
Update on RESOLUTE Phase III trial Regulatory Filings	2025-09-17	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-09-02	English
Total Voting Rights Regulatory Filings	2025-09-01	English
HOLDING(S) IN COMPANY Foreign Filer Report	2025-08-28	English
Holding(s) in Company Major Shareholding Notification	2025-08-28	English
HOLDING(S) IN COMPANY Foreign Filer Report	2025-08-26	English
Holding(s) in Company Major Shareholding Notification	2025-08-26	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-26	Swedish
HOLDING(S) IN COMPANY Foreign Filer Report	2025-08-21	English
Holding(s) in Company Major Shareholding Notification	2025-08-21	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-21	Swedish
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-08-18	English
Director/PDMR Shareholding Director's Dealing	2025-08-18	English
HOLDING(S) IN COMPANY Foreign Filer Report	2025-08-15	English
Holding(s) in Company Major Shareholding Notification	2025-08-15	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-15	Swedish
HOLDING(S) IN COMPANY Foreign Filer Report	2025-08-12	English
Holding(s) in Company Major Shareholding Notification	2025-08-12	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-12	Swedish
TOTAL VOTING RIGHTS Foreign Filer Report	2025-08-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-08-01	English
FORM 6-K Foreign Filer Report	2025-07-29	English
H1 and Q2 2025 results Earnings Release H1 2025	2025-07-29	English
Interim / Quarterly Report 2025 Interim / Quarterly Report H1 2025	2025-07-29	English
GEFURULIMAB NANOBODY MET PHASE III ENDPOINTS Foreign Filer Report	2025-07-24	English
Gefurulimab nanobody met Phase III endpoints Regulatory Filings	2025-07-24	English
ASTRAZENECA PLANS TO INVEST $50BN IN THE US Foreign Filer Report	2025-07-22	English
AstraZeneca plans to invest $50bn in the US Regulatory Filings	2025-07-22	English
UPDATE ON ANSELAMIMAB IN AL AMYLOIDOSIS Foreign Filer Report	2025-07-16	English
Update on anselamimab in AL amyloidosis Regulatory Filings	2025-07-16	English
BAXDROSTAT MET PRIMARY ENDPT IN BAXHTN PHIII TRIAL Foreign Filer Report	2025-07-14	English
Baxdrostat met primary endpt in BaxHTN PhIII trial Earnings Release Q2 2025	2025-07-14	English
Baxdrostat met primary endpt in BaxHTN PhIII trial Earnings Release FY 2025	2025-07-14	English
IMFINZI APPROVED IN THE EU FOR BLADDER CANCER Foreign Filer Report	2025-07-07	English
Imfinzi approved in the EU for bladder cancer Legal Proceedings Report	2025-07-04	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-07-01	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-07-01	English
FORM 11-K Regulatory Filings	2025-06-26	English
DATROWAY APPROVED IN US FOR EGFRM LUNG CANCER Foreign Filer Report	2025-06-24	English
Datroway approved in US for EGFRm lung cancer Regulatory Filings	2025-06-24	English
ASTRAZENECA ENTERS INTO COLLABORATION WITH CSPC Foreign Filer Report	2025-06-13	English
AstraZeneca enters into collaboration with CSPC Regulatory Filings	2025-06-13	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-06-12	English
Director/PDMR Shareholding Director's Dealing	2025-06-12	English
AstraZeneca PLC;AstraZeneca Finance LLC - Base prospectus (debt) Capital/Financing Update	2025-06-12	English
FIXED-DURATION CALQUENCE APPROVED IN EU FOR 1L CLL Foreign Filer Report	2025-06-06	English
Fixed-duration Calquence approved in EU for 1L CLL Regulatory Filings	2025-06-06	English
BLOCK LISTING INTERIM REVIEW Foreign Filer Report	2025-06-02	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-06-02	English
Block listing Interim Review Remuneration Information	2025-06-02	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-06-02	English
IMFINZI RECOMMENDED IN EU FOR BLADDER CANCER Foreign Filer Report	2025-05-27	English
Imfinzi recommended in EU for bladder cancer Regulatory Filings	2025-05-27	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-05-23	English
Director/PDMR Shareholding Director's Dealing	2025-05-23	English
DIRECTOR DECLARATION Foreign Filer Report	2025-05-21	English
Director Declaration Board/Management Information	2025-05-21	English
ACQUISITION OF ESOBIOTEC COMPLETED Foreign Filer Report	2025-05-20	English
Acquisition of EsoBiotec completed M&A Activity	2025-05-20	English
IMFINZI IMPROVED DFS IN EARLY BLADDER CANCER Foreign Filer Report	2025-05-09	English
Imfinzi improved DFS in early bladder cancer Regulatory Filings	2025-05-09	English
ENHERTU IMPROVED PCR IN EARLY-STAGE BREAST CANCER Foreign Filer Report	2025-05-07	English
Enhertu improved pCR in early-stage breast cancer Regulatory Filings	2025-05-07	English
CALQUENCE COMBINATION APPROVED IN EU FOR 1L MCL Foreign Filer Report	2025-05-06	English
Calquence combination approved in EU for 1L MCL Regulatory Filings	2025-05-06	English
BREZTRI MET PRIMARY ENDPOINTS IN PH3 ASTHMA TRIALS Foreign Filer Report	2025-05-02	English
Breztri met primary endpoints in Ph3 asthma trials Regulatory Filings	2025-05-02	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-05-01	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-05-01	English
Director/PDMR Shareholding Director's Dealing	2025-05-01	English
Total Voting Rights Regulatory Filings	2025-05-01	English
FIXED-DURATION CALQUENCE RECOMMENDED IN EU FOR CLL Foreign Filer Report	2025-04-29	English
UPDATE ON CAPITELLO-280 PHASE III TRIAL Foreign Filer Report	2025-04-29	English
1ST QUARTER RESULTS Foreign Filer Report	2025-04-29	English
Fixed-duration Calquence recommended in EU for CLL Earnings Release Q4 2024	2025-04-29	English
Update on CAPItello-280 Phase III trial Legal Proceedings Report	2025-04-29	English
1st Quarter Results Earnings Release Q1 2025	2025-04-29	English
Interim / Quarterly Report 2025 Interim / Quarterly Report Q1 2025	2025-04-29	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-04-24	English
ENHERTU COMBINATION IMPROVED PFS IN 1L HER2+ MBC Foreign Filer Report	2025-04-22	English
Enhertu combination improved PFS in 1L HER2+ mBC Earnings Release Q2 2025	2025-04-22	English
RESULT OF AGM Foreign Filer Report	2025-04-11	English
Result of AGM Declaration of Voting Results & Voting Rights Announcements	2025-04-11	English
Special Business Approved at AGM AGM Information	2025-04-11	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-04-10	English
IMFINZI APPROVED IN EU FOR AEGEAN Foreign Filer Report	2025-04-04	English
ENHERTU APPROVED IN EU IN POST-ET BREAST CANCER Foreign Filer Report	2025-04-04	English
Imfinzi approved in EU for AEGEAN Regulatory Filings	2025-04-04	English
Enhertu approved in EU in post-ET breast cancer Regulatory Filings	2025-04-04	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-04-01	English
Total Voting Rights Regulatory Filings	2025-04-01	English
CALQUENCE RECOMMENDED FOR EU APPROVAL IN 1L MCL Foreign Filer Report	2025-03-31	English
IMFINZI APPROVED IN THE US FOR BLADDER CANCER Foreign Filer Report	2025-03-31	English
Calquence recommended for EU approval in 1L MCL Legal Proceedings Report	2025-03-31	English
Imfinzi approved in the US for bladder cancer Regulatory Filings	2025-03-31	English
AZN INVESTS $2.5BN IN BEIJING R&D & MANUFACTURING Foreign Filer Report	2025-03-21	English
AZN invests $2.5bn in Beijing R&D & manufacturing Regulatory Filings	2025-03-21	English
ENEBOPARATIDE PHASE III TRIAL MET PRIMARY ENDPOINT Foreign Filer Report	2025-03-17	English
IMFINZI APPROVED IN EU FOR LIMITED-STAGE SCLC Foreign Filer Report	2025-03-17	English
ASTRAZENECA TO ACQUIRE ESOBIOTEC Foreign Filer Report	2025-03-17	English
Eneboparatide Phase III trial met primary endpoint Regulatory Filings	2025-03-17	English
Imfinzi approved in EU for limited-stage SCLC Regulatory Filings	2025-03-17	English
AstraZeneca to acquire EsoBiotec M&A Activity	2025-03-17	English
HOLDING(S) IN COMPANY Foreign Filer Report	2025-03-12	English
Holding(s) in Company Major Shareholding Notification	2025-03-12	English
Director's Dealing 2025 Director's Dealing	2025-03-12	Swedish
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-03-07	English
Director/PDMR Shareholding Director's Dealing	2025-03-07	English
NOTICE OF AGM Foreign Filer Report	2025-03-07	English
IMFINZI IMPROVED EFS IN EARLY-STAGE GASTRIC CANCER Foreign Filer Report	2025-03-07	English
FORM 6-K Foreign Filer Report	2025-03-07	English
Notice of AGM AGM Information	2025-03-07	English
Notice of AGM AGM Information	2025-03-07	English
Proxy Form AGM Information	2025-03-07	English
Imfinzi improved EFS in early-stage gastric cancer Regulatory Filings	2025-03-07	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-03-06	English
Director/PDMR Shareholding Director's Dealing	2025-03-06	English
DIRECTOR/PDMR SHAREHOLDING Foreign Filer Report	2025-03-05	English
Director/PDMR Shareholding Director's Dealing	2025-03-05	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-03-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-03-03	English
IMFINZI RECOMMENDED FOR EU APPROVAL FOR AEGEAN Foreign Filer Report	2025-03-03	English
Imfinzi recommended for EU approval for AEGEAN Legal Proceedings Report	2025-03-03	English
ENHERTU RECOMMENDED IN EU IN POST-ET BREAST CANCER Foreign Filer Report	2025-02-28	English
Enhertu recommended in EU in post-ET breast cancer Regulatory Filings	2025-02-28	English
CAMIZESTRANT IMPROVED PFS IN 1L HR+ BREAST CANCER Foreign Filer Report	2025-02-26	English
Camizestrant improved PFS in 1L HR+ breast cancer Regulatory Filings	2025-02-26	English
FILING OF FORM 20-F WITH SEC Foreign Filer Report	2025-02-19	English
Filing of Form 20-F with SEC Report Publication Announcement	2025-02-19	English
IRANNOTICE Regulatory Filings	2025-02-18	English
FORM 20-F Annual Report FY 2024	2025-02-18	English
FORM 6-K Foreign Filer Report	2025-02-18	English
HOLDING(S) IN COMPANY Foreign Filer Report	2025-02-18	English
Holding(s) in Company Major Shareholding Notification	2025-02-18	English
ANNUAL FINANCIAL REPORT Foreign Filer Report	2025-02-18	English
DIRECTORATE CHANGE Foreign Filer Report	2025-02-18	English
Annual Financial Report Report Publication Announcement	2025-02-18	English
Annual Report (ESEF) 2024 Annual Report (ESEF) FY 2024	2025-02-18	English
2024 Annual Report & 20-F Information Annual Report (ESEF) FY 2024	2025-02-18	English
2024 Annual Report & 20-F Information Annual Report FY 2024	2025-02-18	English
Directorate Change Board/Management Information	2025-02-18	English
FINAL RESULTS Foreign Filer Report	2025-02-06	English
Final Results Earnings Release FY 2024	2025-02-06	English
Earnings Release 2024 Earnings Release FY 2024	2025-02-06	English
Regulatory Filings 2025 Regulatory Filings	2025-02-06	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-02-03	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-02-03	English
IMFINZI RECOMMENDED FOR EU APPROVAL FOR LS-SCLC Foreign Filer Report	2025-02-03	English
Imfinzi recommended for EU approval for LS-SCLC Regulatory Filings	2025-02-03	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-01-31	Swedish
ENHERTU APPROVED IN US FOR BREAST CANCER POST ET Foreign Filer Report	2025-01-28	English
Enhertu approved in US for breast cancer post ET Regulatory Filings	2025-01-28	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-01-24	English
Regulatory Filings 2025 Regulatory Filings	2025-01-21	English
DATO-DXD APPROVED IN US FOR HR+ BREAST CANCER Foreign Filer Report	2025-01-21	English
Dato-DXd approved in US for HR+ breast cancer Regulatory Filings	2025-01-20	English
CALQUENCE COMBINATION APPROVED IN US FOR 1L MCL Foreign Filer Report	2025-01-17	English
Calquence combination approved in US for 1L MCL Regulatory Filings	2025-01-17	English
TOTAL VOTING RIGHTS Foreign Filer Report	2025-01-02	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-01-02	English

Filings by year

2026 85 filings
2025 244 filings
2024 214 filings
2023 196 filings
2022 252 filings
2021 318 filings
2020 306 filings
2019 250 filings
2018 226 filings
2017 189 filings
2016 207 filings
2015 192 filings
2014 352 filings
2013 195 filings
2012 42 filings
2011 19 filings
2010 17 filings